Health Care
Viewpoints
Filter by:
ML Strategies Health Care Preview - Week of January 22nd
January 22, 2019|
While Congress is still mired in a partial government shutdown, the Administration is continuing to put out relevant health care regulations and approving new Medicaid work requirements.
The Buzz About Block Grants
January 16, 2019|
With the recent scoop from Politico that the Trump Administration is considering giving states the ability to implement Medicaid block grants, there has been considerable speculation on what the Administration is planning. Although we don’t know exactly what the Administration has in mind, there increasing skepticism on the legality of this move. So we are laying out the fundamentals and past history as we await the final guidance.
ML Strategies Health Care Preview - January 14, 2019
January 15, 2019|
While Congress and the Administration are dug in entering the third week of a partial government shutdown, both branches of government are looking to shape other policy areas in 2019. The Administration is reportedly looking at reforming the Medicaid program and Congress is ramping up its oversight of prescription drug prices.
We cover this and what it will mean for this Congress in this week's preview.
We cover this and what it will mean for this Congress in this week's preview.
ML Strategies Health Care Preview - Week of January 7, 2019
January 7, 2019|
The partial government shutdown is on its 17th day with no end in sight. In this week's preview, we discuss how reaching a solution is challenging for both sides and implications for legislating going forward. We also cover some of the latest polling on health care issues, which may offer a preview into messaging in this space over the next two years.
ML Strategies Weekly Preview - December 17, 2018
December 17, 2018|
This week, Congress is in session for what should be the last week of the 115th Congress. However, the spending fight that has been raging since the last continuing resolution is no closer to being wrapped up than it was a month ago. Additionally, we watch to see if the IMPROVE Act can be finalized this week.
What's Next After the Texas vs. Azar Ruling?
December 17, 2018|
On Friday, December 14th, Judge O’Connor, a Texas Federal District Court Judge, ruled on the case Texas vs. Azar. As background, Texas vs. Azar was filed by 20 Republican state attorneys general and governors. The plaintiffs challenge the constitutionality of the individual mandate in the Affordable Care Act (ACA) and argue that since the individual mandate has been repealed, or more technically zeroed out, the rest of the ACA must be struck down. They argue that the individual mandate cannot be severed from the ACA given its key structural role in the law. The Department of Justice agreed with some, but not all parts, of this argument, and sixteen states and DC are defending the ACA.
Summary of the IMPROVE Act
December 14, 2018|
On December 11, 2018, the House of Representatives passed the IMPROVE Act in a vote of 400-11. The bill is currently moving to the Senate. Our summary of the major provisions of the IMPROVE Act can be found...
Recent State Action Relating to Medicaid Expansion
December 12, 2018|
As of December 2018, 37 states (including D.C.) have adopted Medicaid expansion. Of the remaining 14 states, some are considering expanding Medicaid. States with recent activity relating to Medicaid expansion include: Florida, Idaho, Maine, Missouri, Nebraska, New Hampshire, North Carolina, and Utah. States continue to explore different opportunities as it relates to Medicaid expansion.
ML Strategies Health Care Preview - December 10, 2018
December 10, 2018|
Congress has two weeks to finish up a partial spending deal. For many health care stakeholders, the focus is on finishing the reauthorization of the Money Follows the Person program and passing the ACE Kids Act. While there are other legislative items in the health care space still pending, the current thinking is that policy changes around the doughnut hole or the medical device tax will be left unaddressed.
New Medicare Advantage and Part D Drug Pricing Proposed Rule
December 5, 2018|
On November 26, 2018 the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule, Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses. This proposed rule is the Trump Administration’s latest action to curb prescription drug prices. The proposed rule outlines a number of provisions to for lowering drug prices and reducing out-of-pocket costs in the Part D program that build off the Administration’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
ML Strategies Outlook for 2018
December 5, 2018|
Overview of the Virginia 1115 Medicaid Waiver Application
December 4, 2018|
On November 20, 2018, Virginia submitted an application to CMS for a Section 1115 demonstration program entitled Virginia COMPASS (Creating Opportunities for Medicaid Participants to Achieve Self-Sufficiency). The application comes after Virginia voted in June 2018 to expand its Medicaid program to cover newly eligible non-disabled, non-pregnant adults ages 19 to 64 with income up to 138 percent of the federal poverty level (FPL), on the condition that the expansion include a work requirement and other measures. This waivers implements work requirements and other provisions linked to the state’s Medicaid expansion.
ML Strategies Health Care Preview - Week of December 3rd
December 3, 2018|
This week, Congress is expected to pass a two-week extension to avoid a partial government shutdown.
Overview of CMS' 1332 Waiver Concepts
November 30, 2018|
As we previously discussed, in October the Trump Administration issued guidance related to 1332 waivers. This guidance outlines how the Trump Administration interprets the ACA 1332 waiver guardrails. On November 29th, CMS built off that guidance and outlined four concepts that states can utilize in 1332 waivers. Below is a discussion of these concepts and their potential effects.
Washington Post-Election Check List
November 1, 2018|
ML Strategies Weekly Health Care Preview - October 9, 2018
October 19, 2018|
While the House is out on recess, the Senate continues to be in session. This week the Senate has some non-health care related hearings scheduled as well as nomination hearings. We are looking for signals for a deal to finish work and send vulnerable Senators home to campaign. However, while legislative action may begin to cool down, regulatory activity at OIRA could be heating up.
ML Strategies Weekly Health Care Preview - Week of September 24th
September 24, 2018|
This week, Congress and the White House need to finalize a government spending bill in order to avoid a shutdown. While all signs point to a deal being reached, it is widely expected that several agencies will be operating on a continuing resolution for the first couple months of fiscal year 2019. While the Departments of Labor, HHS, and Education are expected to receive a full appropriation prior to September 30th, the FDA, which is funded through the Department of Agriculture, is expected to be funded through the continuing resolution, which will go through December 7th.
ML Strategies Health Care Preview - Week of September 17th
September 17, 2018|
This week, Congress is off and running with two emerging priorities to complete before members head off to campaign. With the midterms just 50 days away, the longer issues like opioids and appropriations remain unsolved the more likely they are to get punted until after the midterms.
ML Strategies Weekly Health Care Preview – September 10, 2018
September 10, 2018|
Congress continues to make progress towards funding the government despite having only seven business days remaining with both chambers in town prior to the September 30 deadline.
ML Strategies Capitol Hill & Executive Branch Fall Preview
September 6, 2018|
With Labor Day now behind us, Washington returns to a fairly significant workload for September and October in the run-up to the midterm elections in November. The House is in session for the next two weeks before returning home for a state work period (Sept. 17-21). Theoretically, they will then return to DC for three weeks—through October 12—but there's a good chance they will adjourn before that date so that members can campaign in their districts. Although not exhaustive, the following is ML Strategies’ guide on what to watch over the next few months from Capitol Hill and the Executive Branch agencies. While all issues addressed in this update may not be completed before the midterms, we anticipate that they will take up the bulk of the legislative and regulatory agenda. With that said, the Senate has taken up the nomination of Brett Kavanaugh to serve on the Supreme Court and that process has the potential to impact the agenda on other items. With that said, the Senate has taken up the nomination of Brett Kavanaugh to serve on the Supreme Court, and that process has the potential to impact the agenda on other items. We expect the Senate, which remained in session throughout its normal recess period in August, will likely continue to focus on Judicial and Executive branch nominations.
Explore Other Viewpoints:
- Biden Administration
- Crisis Communications/Strategic Public Relations
- Disability & Special Populations
- Education
- Energy & Sustainability
- Federal Government Relations
- Financial Services
- Health Care
- Life Sciences & MedTech
- Real Estate & Project Development
- State & Local Government Relations
- Telecommunications & Technology
- Trade & International Affairs
- Transportation